AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
35 employees · est. 2019 · Menlo Park, United States
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
34 employees · est. 2016 · Cambridge, United Kingdom
Wren Therapeutics is the older company (2019 vs 2016).
Side-by-Side Comparison
| Metric | AN2 Therapeutics | Wren Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2016 older |
| Headquarters | ||
| Headquarters | Menlo Park, United States | Cambridge, United Kingdom |
| Employees | ||
| Employees | 35 | 34 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Grant | Series Unknown |
| Total Funding | ||
| Total Funding | $162.00M | $30.40M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Drug Discovery and Development, Clinical Trials, Research and Innovation in Boron Chemistry, Therapeutic Development for Infectious Diseases and Oncology | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Providers, Medical Research Institutions, Pharmaceutical Companies, Patients with Infectious Diseases, Oncology Patients | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Infectious Diseases, Drug Research, Boron Chemistry, Rare Diseases, Chronic Diseases, Global Health, Drug Development, Transformational Medicines, Biomedical Expertise, Medical Innovation, California-based Company, Industry Leaders | Neurodegenerative Diseases, Biopharmaceutical Company, Drug Discovery, Protein Misfolding Diseases, Small-molecule Therapeutics, Parkinson's Disease, Alzheimer's Disease, ALS, Wren Therapeutics, Cambridge UK, New Technology Platform, Protein Intermediates, Oligomers, Rare Disorders, University Of Cambridge |
| Website | ||
| Website | an2therapeutics.com | wrentherapeutics.com |
About AN2 Therapeutics
AN2 Therapeutics, founded in 2019, is a promising biopharmaceutical startup headquartered in the United States. The company is spearheading efforts in the biotechnology and healthcare sectors with its noteworthy focus on developing therapies for rare, chronic, and serious infectious diseases. The c...
About Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company that has transformed drug discovery for neurodegenerative diseases through its platform, WaveBreak. This platform targets protein intermediates central to disease pathways, specifically focusing on the oligomers that are beyond the reach of convention...
We will tell you when either one moves
BounceWatch watches AN2 Therapeutics and Wren Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AN2 Therapeutics and Wren Therapeutics — by email.
Frequently Asked Questions
Compare AN2 Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at AN2 Therapeutics on 11 Sep 2024, and Wren Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
